Blocking immune checkpoint LAIR1 with antibody blockade or 3-in-1 CAR T cells enhances antitumor response.
Tao H, Chen D, Yang C, Nguyen DT, Abboud G, Liu R, Liu T, Chakraborty A, Hou AY, Petit NA, Abbas M, Davis RW, Zhang J, Von Roemeling C, Gbadamosi MO, Jin L, Gu T, Lin T, Wang P, Pepe A, Pedro DI, Mendez-Gomez HR, Xie C, Karachi A, Weidert F, Jin D, Wang C, Long-James K, Molchan EK, Castillo P, Ligon JA, Ghiaseddin AP, Sayour EJ, Rahman M, Deleyrolle LP, Kim BY, Mitchell DA, Sawyer WG, Huang J.
Tao H, et al. Among authors: liu r.
J Clin Invest. 2025 Jul 1:e184043. doi: 10.1172/JCI184043. Online ahead of print.
J Clin Invest. 2025.
PMID: 40591413